Dimethylamine → HCID 22346324, compound
Reaction equation
[F:1][C:2]1[CH:25]=[CH:24][C:5]([CH2:6][NH:7][C:8]([C:10]2C(OC)=[C:18]3[C:13]([CH:14]=[CH:15][CH:16]=[N:17]3)=[C:12]([NH:22][CH3:23])[N:11]=2)=[O:9])=[CH:4][CH:3]=1.[CH:26]([N:29]([CH:32](C)C)[CH2:30]C)(C)C.ClC(Cl)(O[C:39](=O)[O:40][C:41](Cl)(Cl)Cl)Cl.CNC.C1C[O:53]CC1>C(Cl)Cl>[CH3:26][N:29]([CH3:32])[C:30]([N:22]([CH3:23])[C:12]1[N:11]=[C:10]([C:8]([NH:7][CH2:6][C:5]2[CH:4]=[CH:3][C:2]([F:1])=[CH:25][CH:24]=2)=[O:9])[C:39]([O:40][CH3:41])=[C:18]2[C:13]=1[CH:14]=[CH:15][CH:16]=[N:17]2)=[O:53]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of N-(4-fluorobenzyl)-8-methoxy-5-(methylamino)-1,6-naphthyridine-7-carboxamide(93 mg, 0.27 mmol) in CH2Cl2 (1 mL) at OC was added diisopropylethylamine (0.14 mL, 1.5 mmol) and triphosgene (0.04 g, 0.14 mmol) and the mixture was stirred at room temperature for 16 hr. Additional diisopropylethylamine (0.07 mL, 0.08 mmol) and triphosgene (0.02 g, 0.07 mmol) was added and the reaction was stirred an additional 16 hr at room temperature. A portion of this solution (0.5 mL) was treated with dimethylamine (0.41 mL of a 2M solution in THF, 0.82 mmol). The solvent was evaporated in vacuo and the residue dissolved in DMF (1 mL) and purified by reverse phase HPLC. (Vydak C18, Gradient elution with Water:Acetonitrile 95:5 to 5:95 with 0.1% TFA at 30 mL/min over 15 mins). Lyophilization of the pure fractions afforded the title compound as an off white solid which was used directly in step 3.
Workup
- stirringthe reaction was stirred an additional 16 hr at room temperature
- customThe solvent was evaporated in vacuo
- dissolutionthe residue dissolved in DMF (1 mL)
- custompurified by reverse phase HPLC
- wash(Vydak C18, Gradient elution with Water:Acetonitrile 95:5 to 5:95 with 0.1% TFA at 30 mL/min over 15 mins)
Sources & evidence
- ORD record
- ord-9d95ff91090e4e6f95a3d2be85c6a5dc
- Source dataset
- uspto-grants-2005_07
- Patent number
- US06921759B2
Reaction notes
Loading…